David Baldwin

14.9k total citations · 4 hit papers
229 papers, 7.4k citations indexed

About

David Baldwin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Baldwin has authored 229 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 53 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Baldwin's work include Lung Cancer Diagnosis and Treatment (136 papers), Lung Cancer Treatments and Mutations (75 papers) and Global Cancer Incidence and Screening (48 papers). David Baldwin is often cited by papers focused on Lung Cancer Diagnosis and Treatment (136 papers), Lung Cancer Treatments and Mutations (75 papers) and Global Cancer Incidence and Screening (48 papers). David Baldwin collaborates with scholars based in United Kingdom, United States and Netherlands. David Baldwin's co-authors include Matthew Callister, D. Honeybourne, G. Jones, Robert A. Wise, Richard Hubbard, Laila J. Tata, John K. Field, Stephen W. Duffy, Helen Powell and Anand Devaraj and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Baldwin

218 papers receiving 7.2k citations

Hit Papers

British Thoracic Society ... 2015 2026 2018 2022 2015 2015 2018 2022 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
    2015 604 citations Matthew Callister, David Baldwin et al. Thorax profile →
  2. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules
    2015 544 citations David Baldwin, Matthew Callister Thorax profile →
  3. Recent advances in the management of lung cancer
    2018 325 citations David Baldwin et al. profile →
  4. Lung cancer screening
    2022 228 citations David Baldwin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Baldwin 5.0k 2.0k 1.7k 905 734 229 7.4k
Jean‐Paul Sculier 4.7k 0.9× 1.0k 0.5× 4.3k 2.5× 1.5k 1.6× 1.5k 2.1× 228 8.0k
O Jung Kwon 5.9k 1.2× 2.3k 1.2× 1.3k 0.8× 5.2k 5.7× 688 0.9× 380 13.3k
Ilana F. Gareen 2.3k 0.5× 1.6k 0.8× 1.1k 0.7× 1.0k 1.1× 259 0.4× 80 5.2k
Ronald Feld 4.6k 0.9× 490 0.2× 8.0k 4.7× 3.2k 3.6× 1.7k 2.4× 247 12.9k
Lance K. Heilbrun 2.0k 0.4× 470 0.2× 2.6k 1.5× 687 0.8× 2.1k 2.9× 236 7.8k
Kenji Eguchi 3.8k 0.8× 1.2k 0.6× 2.7k 1.6× 483 0.5× 1.1k 1.5× 249 7.2k
Richard A. Matthay 4.7k 0.9× 560 0.3× 1.1k 0.6× 1.2k 1.4× 1.2k 1.6× 147 7.9k
Michael A. Maddaus 3.8k 0.8× 553 0.3× 1.4k 0.8× 328 0.4× 610 0.8× 130 6.0k
Joseph Aisner 3.9k 0.8× 453 0.2× 5.2k 3.1× 2.4k 2.7× 1.9k 2.5× 308 10.8k
Robert K. Nam 5.4k 1.1× 691 0.3× 1.5k 0.9× 616 0.7× 1.6k 2.2× 165 8.7k

Countries citing papers authored by David Baldwin

Since Specialization
Citations

This map shows the geographic impact of David Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Baldwin more than expected).

Fields of papers citing papers by David Baldwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Baldwin. The network helps show where David Baldwin may publish in the future.

Co-authorship network of co-authors of David Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of David Baldwin. A scholar is included among the top collaborators of David Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Baldwin. David Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thorat, Mangesh A., Marc Arbyn, David Baldwin, et al.. (2025). European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer. Molecular Oncology. 20(1). 117–133. 1 indexed citations
3.
Baldwin, David, Carlijn van der Aalst, Mangesh A. Thorat, et al.. (2025). Screening for lung cancer: A systematic review of overdiagnosis and its implications. Molecular Oncology. 20(3). 611–628. 1 indexed citations
4.
Bhartia, Bobby, David Baldwin, Stephen H Bradley, et al.. (2024). The incidence of lung cancer amongst primary care chest radiograph referrals—an evaluation of national and local datasets within the United Kingdom. British Journal of Radiology. 97(1163). 1769–1774. 1 indexed citations
5.
6.
Landy, Rebecca, David Baldwin, Paul F. Pinsky, et al.. (2023). Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals. JAMA Network Open. 6(3). e233273–e233273. 9 indexed citations
7.
Baldwin, David, et al.. (2023). Important parameters for cost-effective implementation of lung cancer screening. British Journal of Radiology. 96(1145). 20220489–20220489. 4 indexed citations
8.
West, Douglas, John Conibear, Neal Navani, et al.. (2023). The Impact of COVID-19 on Lung Cancer Incidence in England. CHEST Journal. 163(6). 1599–1607. 10 indexed citations
9.
Baldwin, David, et al.. (2023). Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes. Journal of Medical Economics. 27(1). 27–38. 8 indexed citations
10.
Baldwin, David, Richard Booton, Mike Darby, et al.. (2023). Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD. ERJ Open Research. 9(4). 203–2023. 8 indexed citations
11.
O’Dowd, Emma, et al.. (2022). The Future of Lung Cancer Screening: Current Challenges and Research Priorities. SHILAP Revista de lepidopterología. 20 indexed citations
12.
Woznitza, N., Anand Devaraj, Sam M. Janes, et al.. (2022). Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial. Thorax. 78(9). 890–894. 8 indexed citations
13.
Lyne, A. G., et al.. (2019). Reaction times of children having nitrous oxide inhalation sedation for dental procedures. European Archives of Paediatric Dentistry. 21(1). 25–30.
14.
Quaife, Samantha L., Mamta Ruparel, Jennifer Dickson, et al.. (2019). Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials. American Journal of Respiratory and Critical Care Medicine. 201(8). 965–975. 77 indexed citations
15.
16.
Bayman, N., David Ardron, Linda Ashcroft, et al.. (2016). Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention. BMJ Open. 6(1). e010589–e010589. 16 indexed citations
17.
Lifford, Kate, Ben Carter, Fiona E. McRonald, et al.. (2015). Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open. 5(7). e008254–e008254. 143 indexed citations
18.
Pavord, Ian, Elaine Holland, David Baldwin, Anne E. Tattersfield, & Alan J. Knox. (1995). Effect of Diuretics on Allergen-Induced Contractions of Passively Sensitized Human Bronchi In Vitro. American Journal of Respiratory and Critical Care Medicine. 152(4). 1164–1169. 8 indexed citations
19.
Pavord, Ian, et al.. (1993). CROSS REFRACTORINESS BETWEEN SODIUM METABISULFITE AND EXERCISE-INDUCED ASTHMA. American Review of Respiratory Disease. 147. 1 indexed citations
20.
Herbert, F. A., et al.. (1981). Respiratory profiles of grain handlers and sedentary workers.. PubMed Central. 125(1). 46–50. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Paul Sculier Breakdown of academic impact, for papers by O Jung Kwon Breakdown of academic impact, for papers by Ilana F. Gareen Breakdown of academic impact, for papers by Ronald Feld Breakdown of academic impact, for papers by Lance K. Heilbrun Breakdown of academic impact, for papers by Kenji Eguchi Breakdown of academic impact, for papers by Richard A. Matthay Breakdown of academic impact, for papers by Michael A. Maddaus Breakdown of academic impact, for papers by Joseph Aisner Breakdown of academic impact, for papers by Robert K. Nam
Rankless by CCL
2026